Mesalamine Controlled-Release Capsules and Sandostatin LAR Depot injection
Determining the interaction of Mesalamine Controlled-Release Capsules and Sandostatin LAR Depot injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mesalamine Controlled-Release Capsules-Sani-Supp
- Mesalamine Controlled-Release Capsules-Sani-Supp rectal
- Mesalamine Controlled-Release Capsules-Sansert
- Mesalamine Controlled-Release Capsules-Santyl
- Mesalamine Controlled-Release Capsules-Saphris
- Mesalamine Controlled-Release Capsules-Sapropterin
- Sandostatin LAR Depot injection-Mesalamine Delayed Release Tablets
- Sandostatin LAR Depot injection-Mesalamine Long-Acting Capsules (Apriso)
- Sandostatin LAR Depot injection-Mesalamine Long-Acting Capsules (Delzicol)
- Sandostatin LAR Depot injection-Mesalamine Long-Acting Capsules (Pentasa)
- Sandostatin LAR Depot injection-Mesalamine rectal
- Sandostatin LAR Depot injection-Mesalamine Rectal Enema